Pharmacology and clinical evaluation of enalapril maleate and folic acid tabletHUO Yong, CHEN Guang-liang, XU Xi-ping1633-1636
Technical requirements from ICH for preclinical cardiac safety evaluation of pharmaceuticalsCHEN Long, YANG Lin, L(U) Qiang, ZHANG Zhi-hao, ZHAI Jin, ZHANG Jun-ze1642-1647
"FDA's strategic plan for risk communication"and its implication in ChinaNING Yan-yang, YANG Yue1648-1651
Trends in the development of new combination antihypertensive drugs in ChinaHUA Cong-xiao, KANG Cai-lian1652-1656
Preparation and optimization of sustained-release tablets of propafenone hydrochloride β-CD inclusion complexYIN Li-fang, GENG Wen-jun, ZHOU Jian-ping, ZHU Chun-li, ZHANG Lu-yong1657-1660,1668
Relationship between metoprolol-induced dyslipidemia and β2-adrenergic receptor polymorphismsLIU Li-wei, CHEN Guo-liang, LIU Hong, LI Na, LIU Yu-qing, LI Yi-shi1661-1665
Reappraisal of anti-hypertensive drugs in the 2009 edition of European guidelines on hypertension managementGUO Yi-fang1666-1668